Jiang, Xiuxian <br/><br/>
Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.  [electronic resource] 

 -  Molecular cancer therapeutics  Oct 2004 
 - 1221-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Catalytic Domain<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>Crystallography, X-Ray<br/>Cysteine--chemistry<br/>DNA Damage<br/>Dose-Response Relationship, Drug<br/>G2 Phase<br/>Glutamine--chemistry<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Imidazoles--pharmacology<br/>Indoles--antagonists & inhibitors<br/>Inhibitory Concentration 50<br/>Maleimides--antagonists & inhibitors<br/>Models, Chemical<br/>Models, Molecular<br/>Nitrogen--chemistry<br/>Phenotype<br/>Protein Binding<br/>Protein Kinase C--metabolism<br/>Protein Kinase C beta<br/>Protein Kinases--metabolism<br/>Protein Structure, Tertiary<br/>Time Factors